BA.3.2, named the “Cicada” variant, is a new COVID-19 subvariant from the Omicron lineage currently spreading across the US and 23+ countries. First detected in South Africa in late 2024, it carries 70–75 mutations in its spike protein, making it genetically distinct from recent variants. The WHO has classified it as a “variant under monitoring.” No major outbreak has been confirmed in India yet, and there is no evidence that it causes more severe disease than previous strains.
What Is the COVID-19 Cicada Variant (BA.3.2)?
BA.3.2 is a sublineage of the Omicron variant of SARS-CoV-2. The name “Cicada” comes from the idea that this variant may have evolved quietly for a while before reappearing, like a cicada insect that stays dormant before emerging.
BA.3.2 first started infecting people in South Africa in late 2024. It was overcome by other variants, but it reemerged and began causing infections about a year later, following a pattern of being dormant and active, like a cicada.
Scientists say that the cicada carries 70 to 75 new mutations in the spike protein, the portion that the human immune system recognises and targets. That is more than in the more dominant variants that began circulating in 2023.
How Far Has the Cicada Variant Spread?
As of February 11, the BA.3.2 variant has been detected in at least 25 US states, the CDC said. BA.3.2 has been detected in nasal swabs from travellers, aeroplane wastewater samples, clinical samples from patients, and wastewater samples from across multiple states.
As of February 11, 2026, BA.3.2 has spread to at least 23 countries. The majority of cases are in Denmark, Germany, and the Netherlands.
No major outbreak has been linked to BA.3.2 in India yet. Experts advise awareness, not fear.
Also read: Flu Alert in Bangalore: H1N1, H3N2, and RSV on the Rise – Here’s How to Stay Safe
What Are the Symptoms of the Cicada Variant?
Health experts say that the BA.3.2 “Cicada” variant does not seem to cause any new or unusual symptoms compared to other Omicron COVID-19 variants. Loss of taste or smell is now less common but still possible.
The most commonly reported symptoms of BA.3.2 in 2026 include:
- A sore throat is often described as more severe than earlier variants
- Dry cough
- Fever or chills
- Fatigue
- Headache
- Nasal congestion or a runny nose
- Body aches
- Mild breathing difficulties in some cases
- Nausea in some cases
Symptoms can vary depending on the person but usually go away on their own with supportive care. These are often indistinguishable from the symptoms of the common cold, influenza, and RSV, which are also circulating. Testing is crucial to get diagnosed and treated properly.
Is the Cicada Variant More Dangerous Than Previous COVID Variants?
There is no evidence that BA.3.2 is causing more severe disease or hospitalisations in countries where it is more widespread. “It looks scary on paper, but it hasn’t really made a big impact in terms of disease in most places yet,” says virologist Andrew Pekosz from Johns Hopkins.
Although BA.3.2 detections are going up, it is still circulating at a relatively low level in many countries. It has not overtaken the current dominant variants. The WHO noted that “BA.3.2 has not shown a sustained growth advantage over any other co-circulating variant.”
Also read: Nipah Virus in India: Symptoms, How It Spreads, and When You Should See a Doctor
Does the COVID Vaccine Work Against the Cicada Variant?
Because Cicada is part of the Omicron family of COVID viruses, updated vaccines that target Omicron’s dominant strains, such as JN.1, are still effective in fighting BA.3.2. However, they may provide less protection given the changes in the virus.
According to the WHO, current COVID vaccines “are expected to continue providing protection against severe disease.” Vaccines are typically reformulated in the summer and can protect against multiple strains.
“The function of the vaccine is to keep us out of the hospital,” says Dr. William Schaffner of Vanderbilt University. “It’s not very good at preventing milder disease; it works best by averting severe disease.”
Are Antiviral Drugs Effective Against the Cicada Variant?
“The new variant is still sensitive to COVID antiviral drugs that we have been developing, so at least those will work,” say experts. Antiviral medicines like Paxlovid remain effective, particularly for people at higher risk of severe disease.
If you test positive for BA.3.2 and are in a high-risk group, elderly, immunocompromised, or with existing health conditions, consult a doctor promptly about antiviral treatment options. Do not self-medicate.
How to Protect Yourself from the Cicada Variant
The BA.3.2 variant spreads like other COVID-19 variants. You can protect yourself by staying up to date on vaccines, wearing masks in crowded indoor settings, testing when you have symptoms, and staying home when sick.
Additional steps recommended by health experts:
- Wash your hands regularly with soap or a sanitiser with at least 60% alcohol
- Avoid close contact with people showing cold, cough, or fever symptoms
- Keep rooms well-ventilated with fresh air
- Maintain a healthy diet and stay hydrated to support immunity
- Keep frequently touched surfaces clean
Also read: Dengue Warning Signs: When to Seek Emergency Care
When to See a Doctor?
Most people with Cicada variant symptoms recover at home with rest and supportive care. Seek medical attention if you experience:
- Fever above 39°C (103°F) lasting more than a few days
- Symptoms that worsen after initially improving
- Difficulty breathing or shortness of breath
- Persistent chest pain or pressure
- You are elderly, pregnant, immunocompromised, or have existing health conditions
How Clinikk Health Hub Can Help?
If you are experiencing symptoms that might be COVID-related or if you are unsure whether you need a test, a consultation, or a prescription, Clinikk Health Hub offers accessible, doctor-led primary care exactly when you need it.
At Clinikk, you can access rapid COVID testing, doctor consultations, antiviral medication guidance for high-risk patients, and ongoing monitoring for those recovering from COVID. Clinikk’s approach is built around making quality healthcare accessible, whether you are dealing with mild symptoms or managing a higher-risk health situation.
Book a consultation at Clinikk Health Hub
FAQs
What is the new COVID variant in 2026?
The new COVID-19 variant in 2026 is BA.3.2, nicknamed the “Cicada” variant. It is an Omicron subvariant with 70–75 mutations in its spike protein, first detected in South Africa in late 2024 and now spreading globally across 23+ countries.
What are the symptoms of the new COVID Cicada variant?
Symptoms of the BA.3.2 Cicada variant include sore throat, dry cough, fever, fatigue, headache, nasal congestion, body aches, and in some cases mild breathing difficulties or nausea. Symptoms are similar to other Omicron variants and often indistinguishable from the flu or common cold.
Is the Cicada COVID variant in India?
As of April 2026, no major outbreak linked to BA.3.2 has been confirmed in India. However, the variant has spread to 23+ countries globally and is being monitored. Indian health authorities are tracking the situation and advising awareness without panic.
Is the COVID vaccine effective against the new Cicada variant?
Current COVID vaccines targeting the JN.1 lineage still offer protection against severe disease from BA.3.2, though they may be less effective at preventing infection. Health experts strongly recommend staying vaccinated as vaccines continue to protect against hospitalisation and serious illness.
What are antiviral drugs for COVID-19 and do they work against BA.3.2?
Antiviral drugs like Paxlovid remain effective against the Cicada variant. These medicines work best when taken early after a positive test, particularly for people at high risk of severe disease. Always consult a doctor before taking antiviral medication.
How do I download my COVID vaccination certificate?
Your COVID vaccination certificate can be downloaded from the CoWIN portal (cowin.gov.in) by logging in with your registered mobile number. You can also access and download your certificate through the Aarogya Setu app or by visiting your nearest health centre.
How to register for a COVID vaccine in India?
COVID vaccine registration in India can be done through the CoWIN portal at cowin.gov.in or through the Aarogya Setu app. Walk-in registration is also available at government vaccination centres across the country.
Should I get tested if I have symptoms of the Cicada variant?
Yes. Since BA.3.2 symptoms are nearly identical to those of influenza, RSV, and the common cold, testing is the only reliable way to confirm a COVID infection and ensure appropriate treatment. Get a rapid antigen test or RT-PCR test if you have respiratory symptoms.
How many COVID cases are there in India today?
For the most current COVID case count in India, refer to the Ministry of Health and Family Welfare’s official dashboard or the India COVID tracker. Clinikk recommends checking official government sources for the latest daily updates.
Is the Cicada variant causing a new wave in India?
There is no evidence of a BA.3.2-driven wave in India as of April 2026. Health experts globally advise monitoring the situation and following basic precautions rather than panicking. The variant is under WHO surveillance but has not been classified as a high-concern strain.
